Department: DEPARTMENT OF JUSTICE
DEA is proposing amending its regulations to waive the requirement of registration for contract processors, medical/first aid kit providers, distributors of sample packages of drug products, and distributors of research/reference standards pursuant to 21 U.S.C. 822(d). These actions are being taken in response to industry comments and suggestions.
DEA proposes to amend its regulations to require additional
recordkeeping and reporting requirements for drug products containing
gammahydroxybutyric acid (GHB) for which an application has been
approved under the Federal Food, Drug, and Cosmetic Act. DEA proposes [[Page 66049]]
these changes pursuant to section 4 of the ``Hillory J. Farias and
The Department of Justice (DOJ), Federal Bureau of Investigations (FBI) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and